Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry

Por Egerer Gerlinde, Reichert Dietmar, Pletz Mathias W, Kaskel Peter, Krobot Karl J, Maertens Johan
Publicado em 2012-04-01

Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry

Por Egerer, Gerlinde, Reichert, Dietmar, Pletz, Mathias W, Kaskel, Peter, Krobot, Karl J, Maertens, Johan
Publicado em 2012

Economic evaluation of caspofungin vs liposomal amphotericin B for empirical therapy of suspected systemic fungal infection in the German hospital setting

Por Kaskel, Peter, Tuschy, Silja, Wagner, Alexander, Bannert, Christian, Cornely, Oliver A., Glasmacher, Axel, Lipp, Hans-Peter, Ullmann, Andrew J.
Publicado em 2007

Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study

Por Wissing, Heimo, Ballus, Jose, Bingold, Tobias M, Nocea, Gonzalo, Krobot, Karl J, Kaskel, Peter, Kumar, Ritesh N, Mavros, Panagiotis
Publicado em 2013

Patient relevant endpoints in oncology: current issues in the context of early benefit assessment in Germany

Por Dabisch, Inna, Dethling, Jürgen, Dintsios, Charalabos-Markos, Drechsler, Melanie, Kalanovic, Daniel, Kaskel, Peter, Langer, Frank, Ruof, Jörg, Ruppert, Thorsten, Wirth, Daniel
Publicado em 2014

Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study)

Por McArthur, Grant A., Mohr, Peter, Ascierto, Paolo Antonio, Arance, Ana, Banos Hernaez, Ana, Kaskel, Peter, Weichenthal, Michael, Shinde, Reshma, Stevinson, Kendall
Publicado no Oncologist (2017)